# Atrial Fibrillation: In Search for the Optimal Target for Rate Control

> **NCT07135258** · PHASE4 · NOT_YET_RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 200 (estimated)

## Conditions studied

- Atrial Fibrillation (Permanent)
- Atrial Fibrillation (AF)

## Interventions

- **DRUG:** Ivabradine + Usual Care
- **DRUG:** Placebo + usual care

## Key facts

- **NCT ID:** NCT07135258
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135258, "Atrial Fibrillation: In Search for the Optimal Target for Rate Control". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07135258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*